E
Enrico Madon
Researcher at University of Turin
Publications - 91
Citations - 2502
Enrico Madon is an academic researcher from University of Turin. The author has contributed to research in topics: Transplantation & Acute lymphocytic leukemia. The author has an hindex of 26, co-authored 91 publications receiving 2364 citations.
Papers
More filters
Journal ArticleDOI
Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood.
Katia Mareschi,Eleonora Biasin,Wanda Piacibello,Massimo Aglietta,Enrico Madon,Franca Fagioli +5 more
TL;DR: The isolation and characterization of mesenchymal stem cells (MSCs) from bone marrow and umbilical cord blood in a medium with 10% fetal bovine serum (FBS) and 10% horse serum was attempted.
Journal ArticleDOI
Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans
Letizia Mazzini,Franca Fagioli,Riccardo Boccaletti,Katia Mareschi,Giuseppe Oliveri,Carlo Olivieri,Ilaria Pastore,Roberto Marasso,Enrico Madon +8 more
TL;DR: The results appear to demonstrate that the procedures of ex vivo expansion of autologous mesenchymal stem cells and of transplantation into the spinal cord of humans are safe and well tolerated by ALS patients.
Journal ArticleDOI
High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study.
Franca Fagioli,Massimo Aglietta,A. Tienghi,Silvia Ferrari,A. Brach del Prever,E. Vassallo,A. Palmero,Eleonora Biasin,Gaetano Bacci,P. Picci,Enrico Madon +10 more
TL;DR: HDCT combined with surgery is feasible and can induce CR in a large portion of patients, however, only patients who are chemosensitive to induction treatment can obtain CR after HDCT, and the length of remission is short, because most patients relapse.
Journal ArticleDOI
c-kit Is Expressed in Soft Tissue Sarcoma of Neuroectodermic Origin and Its Ligand Prevents Apoptosis of Neoplastic Cells
Emanuela Ricotti,Franca Fagioli,Emanuela Garelli,Claudia Linari,Nicoletta Crescenzio,Alberto L. Horenstein,Paola Pistamiglio,Sergio Vai,Massimo Berger,Luca Cordero diMontezemolo,Enrico Madon,Giuseppe Basso +11 more
TL;DR: The in vitro data indicate that ES and PNET express c-kit and its ligand SCF and that SCF is capable of protecting the tumor cells against apoptosis, and it is assumed thatSCF may also inhibit tumor cell apoptosis in vivo.
Journal ArticleDOI
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995.
Conter,Maurizio Aricò,MG Valsecchi,Giuseppe Basso,Andrea Biondi,Enrico Madon,Franco Mandelli,Guido Paolucci,Andrea Pession,Carmelo Rizzari,Roberto Rondelli,Luigi Zanesco,Giuseppe Masera +12 more
TL;DR: The AIEOP experience shows that CRT can be safely omitted in non-high risk patients, unless they are T-ALL patients with WBC count at the diagnosis ⩾100 000/mm3, and that intensification of treatment allows the improvement of overall results with a reduction of the impact of NCI prognostic criteria.